Headquartered in the USA
Cetalus transactions are confidential
Cetalus transactions are confidential
Animal Health
Transforming human and animal health businesses… Marketing winning products to 2000companies in 50 countries worldwide.
Animal Health
Animal Health –
Experience, Results, Projects
Experience, Results, Projects
Our experience, results and projects are displayed geographically. Please scroll down to your geographical area of interest to see details.
North America
- Available for licensing – Quality of Life Support for companion animals undergoing chemotherapy and radiation
- Pipeline – unique, non-antibiotic, in feed product for performance enhancement
- Number 1 global rank with strategic acquisition for feed business
- Reversed sales decline for global product with new formulations
- Reversed profit decline for global feed business with COGS rationalization
- Enhanced valuation of global business with competitive registrations
Central and South America
- Available for licensing – innovative, proprietary, non-antibiotic, anti-diarrheal in beef and dairy that is commercially successful in a significant and regulated market
- Pipeline – unique, non-antibiotic, in feed product for performance enhancement
- Number 1 global rank with strategic acquisition for feed business
- Reversed sales decline for global product with new formulations
- Reversed profit decline for global feed business with COGS rationalization
- Enhanced valuation of global business with competitive registrations
Asia
- Available for licensing – innovative, proprietary, non-antibiotic, anti-diarrheal in beef and dairy that is commercially successful in a significant and regulated market
- Pipeline – unique, non-antibiotic, in feed product for performance enhancement
- 5X Net Profits for competitive animal health business
- Number 1 global rank with strategic acquisition for feed business
- Reversed Asian trade barrier for US feed supplement
- Reversed sales decline for global product with new formulations
- Reversed profit decline for global feed business with COGS rationalization
- Enhanced valuation of global business with competitive registrations
Europe, Africa
- Available for licensing – innovative, proprietary, non-antibiotic, anti-diarrheal in beef and dairy that is commercially successful in a significant and regulated market
- Available for licensing – Quality of Life Support for companion animals undergoing chemotherapy and radiation
- Pipeline – unique, non-antibiotic, in feed product for performance enhancement
- Number 1 global rank with strategic acquisition for feed business
- Protected European registration for US feed supplement
- Reversed sales decline for global product with new formulations
- Reversed profit decline for global feed business with COGS rationalization
- Enhanced valuation of global business with competitive registrations
- Reversed price decline for European product group
